Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8491
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Buprenorphine–cannabis interaction in patients undergoing opioid maintenance therapy ; day:6 ; month:1 ; year:2020 ; pages:1-10
European archives of psychiatry and clinical neuroscience ; (6.1.2020), 1-10
- Urheber
-
Vierke, Christopher
Marxen, Brigitte
Boettcher, Michael
Hiemke, Christoph
Havemann-Reinecke, Ursula
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00406-019-01091-0
- URN
-
urn:nbn:de:101:1-2020041310101138310691
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vierke, Christopher
- Marxen, Brigitte
- Boettcher, Michael
- Hiemke, Christoph
- Havemann-Reinecke, Ursula
- SpringerLink (Online service)
Ähnliche Objekte (12)
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Single high-dose buprenorphine for opioid craving during withdrawal
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
Buprenorphine - the unique opioid analgesic : pharmacology and clinical application ; 13 tables
Buprenorphine – The ideal drug for most clinical indications for an opioid?
Lower buprenorphine elimination rate constant is associated with lower opioid use
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series